LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Caplice, Noel M"
  2. AU="Muzi, Stefania"
  3. AU="Fried, Daniel"
  4. AU=Majidi Hadi
  5. AU="Kilpatrick, Laura E"
  6. AU="Cantero, Chloé"
  7. AU="Minatani, Shinobu"
  8. AU=Wang Yueying
  9. AU="Wagner, Holger"
  10. AU="Blinkey, Neil"
  11. AU=Jiang Yi

Suchergebnis

Treffer 1 - 10 von insgesamt 103

Suchoptionen

  1. Artikel ; Online: High-fidelity porcine models of metabolic syndrome: a contemporary synthesis.

    Cluzel, Gaston L / Ryan, Paul M / Herisson, Florence M / Caplice, Noel M

    American journal of physiology. Endocrinology and metabolism

    2022  Band 322, Heft 4, Seite(n) E366–E381

    Abstract: This review aims to describe and compare porcine models of metabolic syndrome. This syndrome and its associated secondary comorbidities are set to become the greatest challenge to healthcare providers and policy makers in the coming century. However, an ... ...

    Abstract This review aims to describe and compare porcine models of metabolic syndrome. This syndrome and its associated secondary comorbidities are set to become the greatest challenge to healthcare providers and policy makers in the coming century. However, an incomplete understanding of the pathogenesis has left significant knowledge gaps in terms of efficacious therapeutics. To further our comprehension and, in turn, management of metabolic syndrome, appropriate high-fidelity models of the disease complex are of great importance. In this context, our review aims to assess the most promising porcine models of metabolic syndrome currently available for their similarity to the human phenotype. In addition, we aim to highlight the strengths and shortcomings of each model in an attempt to identify the most appropriate application of each. Although no porcine model perfectly recapitulates the human metabolic syndrome, several pose satisfactory approximations. The Ossabaw miniature swine in particular represents a highly translatable model that develops each of the core parameters of the syndrome with many of the associated secondary comorbidities. Future high-fidelity porcine models of metabolic syndrome need to focus on secondary sequelae replication, which may require extended induction period to reveal.
    Mesh-Begriff(e) Animals ; Disease Models, Animal ; Disease Progression ; Metabolic Syndrome/etiology ; Swine ; Swine, Miniature
    Sprache Englisch
    Erscheinungsdatum 2022-02-28
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00413.2021
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Mesenchymal stromal cell derived CCL2 is required for accelerated wound healing.

    Whelan, Derek S / Caplice, Noel M / Clover, Anthony J P

    Scientific reports

    2020  Band 10, Heft 1, Seite(n) 2642

    Abstract: Mesenchymal stromal cells (MSC) have immunomodulatory effects impacting macrophages, promoting polarisation towards a reparative phenotype. CCL2 is a potent cytokine involved in the recruitment of macrophages. We hypothesised that MSC derived CCL2 may be ...

    Abstract Mesenchymal stromal cells (MSC) have immunomodulatory effects impacting macrophages, promoting polarisation towards a reparative phenotype. CCL2 is a potent cytokine involved in the recruitment of macrophages. We hypothesised that MSC derived CCL2 may be involved in the MSC therapeutic effect by facilitating macrophage repolarisation. To further delineate this mechanism, MSC isolated from CCL2 deficient mice (MSC-KO) were applied to excisional wounds in wild-type (WT) mice. CCL2 deficiency in MSC completely abrogated the therapeutic response compared to MSC-WT. MSC-KO were unable to repolarise macrophages to the same extent as WT and this was accompanied by a reduced angiogenesis and re-epithelialisation of the wounds at day 10. This study demonstrates that MSC derived CCL2 is required for MSC induced accelerated wound healing. The role of CCL2 in the interaction between MSC and Macrophages has not been previously demonstrated in accelerated wound healing. CCL2 has a potent effect on the ability to reduce the inflammatory response through local recruitment of macrophages. This research highlights CCL2 as a possible target for augmentation of MSC therapy to enhance therapeutic potential.
    Mesh-Begriff(e) Animals ; Cell Polarity ; Chemokine CCL2/metabolism ; Disease Models, Animal ; Female ; Immunity, Innate ; Immunomodulation ; Inflammation/pathology ; Lectins, C-Type/metabolism ; Macrophages/metabolism ; Mannose-Binding Lectins/metabolism ; Mesenchymal Stem Cells/metabolism ; Mice, Inbred C57BL ; Mice, Transgenic ; Neovascularization, Physiologic ; Re-Epithelialization ; Receptors, Cell Surface/metabolism ; Wound Healing
    Chemische Substanzen Chemokine CCL2 ; Lectins, C-Type ; Mannose-Binding Lectins ; Receptors, Cell Surface ; mannose receptor
    Sprache Englisch
    Erscheinungsdatum 2020-02-14
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-020-59174-1
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?

    Ryan, Paul MacDaragh / Caplice, Noel M

    Obesity (Silver Spring, Md.)

    2020  Band 28, Heft 7, Seite(n) 1191–1194

    Abstract: Coronavirus disease 2019 (COVID-19), the worst pandemic in more than a century, has claimed >125,000 lives worldwide to date. Emerging predictors for poor outcomes include advanced age, male sex, preexisting cardiovascular disease, and risk factors ... ...

    Abstract Coronavirus disease 2019 (COVID-19), the worst pandemic in more than a century, has claimed >125,000 lives worldwide to date. Emerging predictors for poor outcomes include advanced age, male sex, preexisting cardiovascular disease, and risk factors including hypertension, diabetes, and, more recently, obesity. This article posits new obesity-driven predictors of poor COVID-19 outcomes, over and above the more obvious extant risks associated with obesity, including cardiometabolic disease and hypoventilation syndrome in intensive care patients. This article also outlines a theoretical mechanistic framework whereby adipose tissue in individuals with obesity may act as a reservoir for more extensive viral spread, with increased shedding, immune activation, and cytokine amplification. This paper proposes studies to test this reservoir concept with a focus on specific cytokine pathways that might be amplified in individuals with obesity and COVID-19. Finally, this paper underscores emerging therapeutic strategies that might benefit subsets of patients in which cytokine amplification is excessive and potentially fatal.
    Mesh-Begriff(e) Adipose Tissue/virology ; Betacoronavirus/immunology ; COVID-19 ; Coronavirus Infections/immunology ; Coronavirus Infections/virology ; Cytokines/metabolism ; Humans ; Lymphocyte Activation/immunology ; Obesity/immunology ; Obesity/virology ; Pandemics ; Pneumonia, Viral/immunology ; Pneumonia, Viral/virology ; SARS-CoV-2
    Chemische Substanzen Cytokines
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-05-31
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2230457-5
    ISSN 1930-739X ; 1071-7323 ; 1930-7381
    ISSN (online) 1930-739X
    ISSN 1071-7323 ; 1930-7381
    DOI 10.1002/oby.22843
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: A state-of-the-art review of the current role of cardioprotective techniques in cardiac transplantation.

    Cullen, Paul P / Tsui, Steven S / Caplice, Noel M / Hinchion, John A

    Interactive cardiovascular and thoracic surgery

    2021  Band 32, Heft 5, Seite(n) 683–694

    Abstract: Objectives: The use of 'extended criteria' donor hearts and reconditioned hearts from donation after circulatory death has corresponded with an increase in primary graft dysfunction, with ischaemia-reperfusion injury being a major contributing factor in ...

    Abstract Objectives: The use of 'extended criteria' donor hearts and reconditioned hearts from donation after circulatory death has corresponded with an increase in primary graft dysfunction, with ischaemia-reperfusion injury being a major contributing factor in its pathogenesis. Limiting ischaemia-reperfusion injury through optimising donor heart preservation may significantly improve outcomes. We sought to review the literature to evaluate the evidence for this.
    Methods: A review of the published literature was performed to assess the potential impact of organ preservation optimisation on cardiac transplantation outcomes.
    Results: Ischaemia-reperfusion injury is a major factor in myocardial injury during transplantation with multiple potential therapeutic targets. Innate survival pathways have been identified, which can be mimicked with pharmacological conditioning. Although incompletely understood, discoveries in this domain have yielded extremely encouraging results with one of the most exciting prospects being the synergistic effect of selected agents. Ex situ heart perfusion is an additional promising adjunct.
    Conclusions: Cardiac transplantation presents a unique opportunity to perfuse the whole heart before, or immediately after, the onset of ischaemia, thus maximising the potential for global cardioprotection while limiting possible systemic side effects. While clinical translation in the setting of myocardial infarction has often been disappointing, cardiac transplantation may afford the opportunity for cardioprotection to finally deliver on its preclinical promise.
    Mesh-Begriff(e) Heart ; Heart Transplantation/adverse effects ; Humans ; Myocardial Infarction ; Organ Preservation ; Tissue Donors
    Sprache Englisch
    Erscheinungsdatum 2021-04-23
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2095298-3
    ISSN 1569-9285 ; 1569-9293
    ISSN (online) 1569-9285
    ISSN 1569-9293
    DOI 10.1093/icvts/ivaa333
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Role of vessel wall and bone marrow syndecan-4 in neointimal hyperplasia: the plot thickens.

    Caplice, Noel M

    Arteriosclerosis, thrombosis, and vascular biology

    2011  Band 31, Heft 5, Seite(n) 952–953

    Mesh-Begriff(e) Animals ; Apoptosis ; Bone Marrow Cells/metabolism ; Bone Marrow Cells/pathology ; Bone Marrow Transplantation ; Cell Movement ; Cell Proliferation ; Disease Models, Animal ; Femoral Artery/injuries ; Femoral Artery/metabolism ; Femoral Artery/pathology ; Hyperplasia ; Mice ; Muscle, Smooth, Vascular/injuries ; Muscle, Smooth, Vascular/metabolism ; Muscle, Smooth, Vascular/pathology ; Myocytes, Smooth Muscle/metabolism ; Myocytes, Smooth Muscle/pathology ; Signal Transduction ; Stem Cells/metabolism ; Stem Cells/pathology ; Syndecan-4/metabolism ; Tunica Intima/injuries ; Tunica Intima/metabolism ; Tunica Intima/pathology ; Vascular System Injuries/metabolism ; Vascular System Injuries/pathology
    Chemische Substanzen Sdc4 protein, mouse ; Syndecan-4
    Sprache Englisch
    Erscheinungsdatum 2011-05
    Erscheinungsland United States
    Dokumenttyp Comment ; Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 1221433-4
    ISSN 1524-4636 ; 1079-5642
    ISSN (online) 1524-4636
    ISSN 1079-5642
    DOI 10.1161/ATVBAHA.111.225557
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Obesity and COVID-19: A Virchow's Triad for the 21st Century.

    Vaughan, Carl J / Cronin, Heather / Ryan, Paul MacDaragh / Caplice, Noel M

    Thrombosis and haemostasis

    2020  Band 120, Heft 11, Seite(n) 1590–1593

    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-07-17
    Erscheinungsland Germany
    Dokumenttyp Letter ; Comment
    ZDB-ID 518294-3
    ISSN 2567-689X ; 0340-6245
    ISSN (online) 2567-689X
    ISSN 0340-6245
    DOI 10.1055/s-0040-1714216
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: COVID-19-Where Have All the STEMIs Gone?

    Tanner, Richard / MacDaragh Ryan, Paul / Caplice, Noel M

    The Canadian journal of cardiology

    2020  Band 36, Heft 7, Seite(n) 1161.e9–1161.e10

    Mesh-Begriff(e) Angioplasty, Balloon, Coronary/methods ; Angioplasty, Balloon, Coronary/statistics & numerical data ; COVID-19 ; Coronavirus Infections/epidemiology ; Female ; Hospital Mortality/trends ; Humans ; Incidence ; Infection Control/methods ; Italy/epidemiology ; Male ; Pandemics ; Pneumonia, Viral/epidemiology ; Risk Assessment ; ST Elevation Myocardial Infarction/diagnostic imaging ; ST Elevation Myocardial Infarction/epidemiology ; ST Elevation Myocardial Infarction/therapy ; Survival Analysis
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-05-01
    Erscheinungsland England
    Dokumenttyp Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 632813-1
    ISSN 1916-7075 ; 0828-282X
    ISSN (online) 1916-7075
    ISSN 0828-282X
    DOI 10.1016/j.cjca.2020.04.032
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel: Exploring the Gut Microbiota and Cardiovascular Disease.

    Murphy, Kiera / O'Donovan, Aoife N / Caplice, Noel M / Ross, R Paul / Stanton, Catherine

    Metabolites

    2021  Band 11, Heft 8

    Abstract: Cardiovascular disease (CVD) has been classified as one of the leading causes of morbidity and mortality worldwide. CVD risk factors include smoking, hypertension, dyslipidaemia, obesity, inflammation and diabetes. The gut microbiota can influence human ... ...

    Abstract Cardiovascular disease (CVD) has been classified as one of the leading causes of morbidity and mortality worldwide. CVD risk factors include smoking, hypertension, dyslipidaemia, obesity, inflammation and diabetes. The gut microbiota can influence human health through multiple interactions and community changes are associated with the development and progression of numerous disease states, including CVD. The gut microbiota are involved in the production of several metabolites, such as short-chain fatty acids (SCFAs), bile acids and trimethylamine-N-oxide (TMAO). These products of microbial metabolism are important modulatory factors and have been associated with an increased risk of CVD. Due to its association with CVD development, the gut microbiota has emerged as a target for therapeutic approaches. In this review, we summarise the current knowledge on the role of the gut microbiome in CVD development, and associated microbial communities, functions, and metabolic profiles. We also discuss CVD therapeutic interventions that target the gut microbiota such as probiotics and faecal microbiota transplantation.
    Sprache Englisch
    Erscheinungsdatum 2021-07-29
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2662251-8
    ISSN 2218-1989
    ISSN 2218-1989
    DOI 10.3390/metabo11080493
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel: Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?

    Ryan, Paul MacDaragh / Caplice, Noel M

    Obesity (Silver Spring)

    Abstract: Coronavirus disease 2019 (COVID-19), the worst pandemic in more than a century, has claimed >125,000 lives worldwide to date. Emerging predictors for poor outcomes include advanced age, male sex, preexisting cardiovascular disease, and risk factors ... ...

    Abstract Coronavirus disease 2019 (COVID-19), the worst pandemic in more than a century, has claimed >125,000 lives worldwide to date. Emerging predictors for poor outcomes include advanced age, male sex, preexisting cardiovascular disease, and risk factors including hypertension, diabetes, and, more recently, obesity. This article posits new obesity-driven predictors of poor COVID-19 outcomes, over and above the more obvious extant risks associated with obesity, including cardiometabolic disease and hypoventilation syndrome in intensive care patients. This article also outlines a theoretical mechanistic framework whereby adipose tissue in individuals with obesity may act as a reservoir for more extensive viral spread, with increased shedding, immune activation, and cytokine amplification. This paper proposes studies to test this reservoir concept with a focus on specific cytokine pathways that might be amplified in individuals with obesity and COVID-19. Finally, this paper underscores emerging therapeutic strategies that might benefit subsets of patients in which cytokine amplification is excessive and potentially fatal.
    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #525894
    Datenquelle COVID19

    Kategorien

  10. Buch ; Artikel ; Online: Is adipose tissue a reservoir for viral spread, immune activation and cytokine amplification in COVID-19?

    Ryan, Paul MacDaragh / Caplice, Noel M.

    2020  

    Abstract: Coronavirus disease 2019 (COVID-19), the worst pandemic in more than a century, has claimed >125,000 lives worldwide to date. Emerging predictors for poor outcome include advanced age, male gender, pre-existing cardiovascular disease and risk factors ... ...

    Abstract Coronavirus disease 2019 (COVID-19), the worst pandemic in more than a century, has claimed >125,000 lives worldwide to date. Emerging predictors for poor outcome include advanced age, male gender, pre-existing cardiovascular disease and risk factors including hypertension, diabetes and more recently obesity. Herein, we posit new obesity-driven predictors of poor COVID-19 outcome, over and above the more obvious extant risks associated with obesity including cardiometabolic disease and hypoventilation syndrome in intensive care patients. We outline a theoretical mechanistic framework whereby adipose tissue in subjects with obesity may act as a reservoir for more extensive viral spread with increased shedding, immune activation and cytokine amplification. We propose studies to test this reservoir concept with a focus on specific cytokine pathways that might be amplified in subjects with obesity and COVID-19. Finally, we underscore emerging therapeutic strategies that might benefit subsets of patients in which cytokine amplification is excessive and potentially fatal.
    Schlagwörter Obesity ; Poor COVID-19 outcome ; Adipose tissue ; Cytokine pathways ; Cytokine amplification ; covid19
    Thema/Rubrik (Code) 610 ; 616
    Sprache Englisch
    Erscheinungsdatum 2020-04-21
    Verlag John Wiley & Sons, Inc.
    Erscheinungsland ie
    Dokumenttyp Buch ; Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang